less land expenses and legal fee. Loss from change in fair value of biological assets : The subsidiary (UPOIC) realized loss from change in fair value of biological assets of Baht 4.6 million (Q1/2019

consolidated EBITDA in 1Q2020 was THB 751. 67 million, increased by THB 147.95 million or 24.51% up from 1Q2019. Financial Highlights 1Q 2020 1Q 2019 Change THB million % Sales THB million % Sales THB million

due to; Highlights: 1st quarter of FY 2020 Operating results 1st quarter 1st quarter 4th quarter % Change FY 2020 FY 2019 FY 2019 (YoY) (QoQ) Revenue from sales and services 1,828 100% 1,866 100% 2,269

for rent and Baht 5.4 Million from gain on change in fair value less cost of sale of biological assets. Financial Cost Financial cost in Q2/2020 was Baht 8.1 Million had decreased by Baht 0.4 Million or

ทางการเงิน สำหรับงวดหกเดือนสิ้นสุดวันที่ 30 มิถุนายน 2563 และ 30 มิถุนายน 2562 ดังนี้: Q2 2563 Q2 2562 YoY change YoY % change หน่วย: ล้านบาท รายได้จากการขายและบริการ 232.44 229.27 3.17 1% รายได้อ่ืน 3.27

Thailand Sustainability Investment 4/ Thailand Sustainability Investment n/a Ranking by Industry Business 4/ Market/Industry/Sector Change Effective Date 02/07/2015 Previous Market/Industry/Sector SET

ratio did not exceed 3.00 times, which is the covenant for bank loans and debentures. 3 Income Statement For the year ended December 31 Change Unit: Million Baht 2019 2018 Amount % Revenues from

Limited, equivalent to 3,311,172.50 baht. After the transaction is completed, CWTG will hold approximately 100% of the shares in GP1 And all sold. Shareholding structure: Before Change Shareholding

of the plant and machineries from an independent engineering expert. The effect of such change in the estimated useful lives of assets to the depreciation charge during the quarter is as below; Unit

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech